Friday, December 19, 2025 | 05:03 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

PlasmaGen Biosciences hopes for turnover of Rs 640 crore in five years

Awareness of human plasma products and their utility is still nascent

PlasmaGen BioSciences
premium

PlasmaGen BioSciences founder Vinod Nahar with Chief Executive Ranjeet S Ajmani and Director Rahul Jain. Photo: Saggere Radhakrishna

Sohini Das
PlasmaGen BioSciences, a start-up in the niche area of plasma products, incorporated in September 2010, is working on creating a manufacturing facility near Bengaluru. It aims to touch a turnover of $100-120 million (Rs 640-800 crore) in the next five years.

Plasma products

Blood plasma is a liquid component of blood that normally holds the blood cells (red, white and platelets). Human plasma contains proteins like serum albumins, immuno-globulins, fibrinogen and clotting factors, which have  various therapeutic uses. These are used for patients with Haemophilia, fibrinogen deficiency, and burn and trauma patients, among others. It is considered safer